SEC Form 4 · accession 0001104659-19-014545
Apellis Pharmaceuticals, Inc. · APLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morningside Venture Investments Ltd
10% Owner
Period of report
Mar 11, 2019
Accepted (ET)
Mar 13, 2019 · 3:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492422
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 11, 2019 | P | 441,176 | $17.00 | A | 12,015,802 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.